Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus

Recombinant poxviruses, utilized as vaccine vectors and oncolytic viruses, often require manipulation at multiple genetic loci in the viral genome. It is essential for viral vectors to possess no adventitious mutations and no (antibiotic) selection marker in the final product for human patients in o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zong Sheng Guo, Zuqiang Liu, Magesh Sathaiah, Jiahu Wang, Roshni Ravindranathan, Eun Kim, Shaohua Huang, Thomas W. Kenniston, John C. Bell, Herbert J. Zeh, III, Lisa H. Butterfield, Andrea Gambotto, David L. Bartlett
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2017-12-01
Serie:Molecular Therapy: Methods & Clinical Development
Soggetti:
vaccinia virus
oncolytic virus
vaccine
cancer
method
marker-free poxvirus
clinical grade
immunotherapy
Accesso online:http://www.sciencedirect.com/science/article/pii/S2329050117301067
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi